{"doi":"10.1007/s40138-017-0137-2","title":"Entresto (Sacubitril/Valsartan): Angiotensin Receptor Neprilysin Inhibition for Treating Heart Failure","abstract":null,"journal":"Current Emergency and Hospital Medicine Reports","year":2017,"id":635401,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1648491,"name":"Barry H. Greenberg","orcid":null,"position":1,"is_corresponding":false},{"id":639105,"name":"Nicholas Phreaner","orcid":"0000-0002-2682-2593","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Entresto (Sacubitril/Valsartan): Angiotensin Receptor Neprilysin Inhibition for Treating Heart Failure","abstract":null,"is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19910364","pmcid":null,"openalex_id":"https://openalex.org/W2604998822","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.0654671,"influential_citations":0,"citation_trend":[{"year":2025,"count":2}],"oa_status":"closed","license":"http://www.springer.com/tdm","oa_locations":[{"url":"http://link.springer.com/article/10.1007/s40138-017-0137-2/fulltext.html","host_type":"publisher"},{"url":"http://link.springer.com/content/pdf/10.1007/s40138-017-0137-2.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1007/s40138-017-0137-2","host_type":"journal"}],"fields_of_study":["Heart Failure Treatment and Management","Cardiovascular Function and Risk Factors","Blood Pressure and Hypertension Studies"],"mesh_terms":[],"keywords":["Sacubitril","Valsartan","Sacubitril, Valsartan","Heart failure","Medicine","Ejection fraction","Discontinuation","Cardiology","Internal medicine","Myocardial infarction","Angiotensin receptor","Angiotensin II","Intensive care medicine","Blood pressure"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T15:02:55.678302Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}